Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Daewon Pharmaceutical Co., Ltd.
Age
19–49
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Healthy male who are ≥19, \<50 years old
Man who weights over 55kg and whose BMI is 18\~30(kg/m2)
Man who doesn't have any chronic disease or history of disease
You may not be if
man who has or had any clinically relevant disease of liver, kidney, nervous/respiratory/musculoskeletal/cardiovascular/hemato-oncology system or neuropsychiatry
Clareo Health | Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
